Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Prothena (PRTA)

Prothena Corporation PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PRTA
DateTimeSourceHeadlineSymbolCompany
04/01/202500:45Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:PRTAProthena Corporation PLC
30/12/202421:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRTAProthena Corporation PLC
30/12/202421:05Business WireProthena Announces Board of Directors UpdateNASDAQ:PRTAProthena Corporation PLC
19/12/202406:05Business WireRoche’s Phase IIb Study of Prasinezumab Missed Primary Endpoint, But Suggests Possible Clinical Benefit in Early-Stage Parkinson’s DiseaseNASDAQ:PRTAProthena Corporation PLC
13/11/202412:00Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:PRTAProthena Corporation PLC
12/11/202421:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRTAProthena Corporation PLC
12/11/202421:05Business WireProthena Reports Third Quarter 2024 Financial Results and Business HighlightsNASDAQ:PRTAProthena Corporation PLC
05/11/202421:05Business WireProthena to Report Third Quarter 2024 Financial Results on November 12NASDAQ:PRTAProthena Corporation PLC
03/10/202422:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
03/10/202422:57Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
27/09/202420:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRTAProthena Corporation PLC
27/09/202420:05Business WireProthena Announces Leadership Team UpdatesNASDAQ:PRTAProthena Corporation PLC
29/08/202420:05Business WireProthena to Participate in Upcoming Healthcare ConferencesNASDAQ:PRTAProthena Corporation PLC
08/08/202421:13Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PRTAProthena Corporation PLC
08/08/202420:14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PRTAProthena Corporation PLC
08/08/202420:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRTAProthena Corporation PLC
08/08/202420:05Business WireProthena Reports Second Quarter 2024 Financial Results and Business HighlightsNASDAQ:PRTAProthena Corporation PLC
01/08/202420:05Business WireProthena to Report Second Quarter 2024 Financial Results on August 8NASDAQ:PRTAProthena Corporation PLC
28/05/202420:05Business WireProthena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development CollaborationNASDAQ:PRTAProthena Corporation PLC
17/05/202420:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
17/05/202420:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
17/05/202420:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
17/05/202420:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRTAProthena Corporation PLC
08/05/202420:19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PRTAProthena Corporation PLC
08/05/202420:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRTAProthena Corporation PLC
08/05/202420:05Business WireProthena Reports First Quarter 2024 Financial Results and Business HighlightsNASDAQ:PRTAProthena Corporation PLC
01/05/202420:05Business WireProthena to Report First Quarter 2024 Financial Results on May 8NASDAQ:PRTAProthena Corporation PLC
15/04/202420:05Business WireProthena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & LymphomaNASDAQ:PRTAProthena Corporation PLC
06/03/202402:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
06/03/202402:01Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
 Showing the most relevant articles for your search:NASDAQ:PRTA